Tue, Jul 22, 2014, 5:58 AM EDT - U.S. Markets open in 3 hrs 32 mins

Recent

% | $
Click the to save as a favorite.

Amarin Corporation plc Message Board

  • staccani staccani Dec 27, 2013 1:21 PM Flag

    Question to the CP promoters

    Dear all,
    I have reviewed the very interesting material posted on the epadruginitiative site. First of all I would like to thank you for the big effort of putting the material together and the enornous due diligence done.
    I gave my small contribution by signing the petition a few weeks ago, and I am more and more convinced that there might be sufficient elements to start a criminal investigation against the FDA or some specific members, and this regardless of the outcome of the ANCHOR SPA reinstatement and/or VASCEPA approval for wider use. Whilst it might be prudent to wait for a possible overturn of ANCHOR SPA rescission, I believe that if there was any wrongdoing (it is difficult to imagine that all those alleged data manipulation, misinterpretation and deceitful representation are simply due to genuine mistakes), this should be rightfully investigated and prosecuted, if applicable. Your thoughts are welcome.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • I completely agree that their was wrong doing and harm by the FDA's manipulation of ADCOM outcome and hasty SPA rescission, and the harm can't be undone by reinstating the SPA. multi-millions were lost in options that can't be recovered even if AMRN's market cap were to recover back to one billion.
      I personally won't have a case for loss because I aggressively averaged down and reached a break even point in the low $2's where I scaled back significantly in prep for any additional FDA bombs. However, I'm pi$$ed by what I have witnessed here and have arranged to present this FDA corruption case to a very large and successful national legal firm. One of their top lawyers is a good friend of mine. He asked that I provide a summary so that he and his staff could evaluate the merit of the case. Most of the case has already been summarized on EPAdruginitative so thanks to everyone who put that site together....it's a one stop shop for lawyers who may eventually take up this fight on behalf of investors who were wronged by the FDA.
      I'll let everyone know what my lawyer friend recommends after his review. Whether his team takes up the fight or not, he will likely provide off the record opinions that might help guide our quest. By the way, he has represented cases all the way to the Supreme Court. He's quite the "Who's who" of lawyers which is why I think this case might get his attention.
      Finally, I recommend anyone else who has lawyer friends do the same as me. This is the kind of case that would give them national exposure, not to mention a hefty pay day once they win...and they will win if there is any integrity left in this county!

    • Staccani
      I believe the central issue will be whether the 3 trials cited to rescind the SPA....stand up to scrutiny, legally.
      The three trials ...ACCORD , Aim High and Thrive used patients with TG's levels in the mid 160's ....not in the 200-500 range of the Anchor indication.
      So its our position ( Epadruginitiative group ) that based on those trials using different drugs , the FDA can not extrapolate and say there is no benefit in the high TG group ( 200-500 ) using a different mechanism of action especially since benefit was seen in all trials with the sub group high TG /low HDL

      We have other issues with the FDA ...how the Adcom was handled ...disregard for data from the Jelis trial etc but I think our central argument is as outlined above .

      These are just my opinions ...I am not authorized to speak for the group but I will ask they post more info here in case you and others are interested.
      AK

    • Amen!

    • It appears staccani that panel members of the FDA (and others) blew the whistle on themselves .... the stuttering and "I don't understand the question" that went on in that meeting was the first obvious tipoff .... which led to the changing of the goal posts as a last resort .( in short form ) ... It appears that the first order of business is to anchor SPA .. :)
      And should that occur, that won't change the losses that investors have incurred .... there has been tremendous loss with options play for investors and an increase in stock price will never recoup those losses ..... I can only imagine how many would be willing to take a partial hit on those options to see those who are/were part of this corrupt play tied to the whipping post .......

      • 1 Reply to morganlondonstrategy
      • Staccani
        One lesson learned growing up in a some what working class neighborhood is that if you are going to pick a fight .....pick a fight you have a chance of winning.
        Taking on the FDA on the basis of possible corruption ( I acknowledge some may exist ) is wasted effort at this time.
        Focusing in on a key scientific argument where the evidence supports our position ..( you can not extrapolate the data from the 3 trials cited to justify rescinding the SPA ) .....that fight we have a chance of winning .

        By the way ...note Williams has been remarkably restrained of late and made a very compelling
        argument based on the science , in a recent CP comment .
        JMO
        AK

 
AMRN
1.52+0.01(+0.66%)Jul 21 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Netflix, Inc.
NasdaqGSMon, Jul 21, 2014 4:00 PM EDT